These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. The epidemiology of methamphetamine use and harm in Australia. Degenhardt L, Roxburgh A, Black E, Bruno R, Campbell G, Kinner S, Fetherston J. Drug Alcohol Rev; 2008 May; 27(3):243-52. PubMed ID: 18368605 [Abstract] [Full Text] [Related]
11. Major physical and psychological harms of methamphetamine use. Darke S, Kaye S, McKetin R, Duflou J. Drug Alcohol Rev; 2008 May; 27(3):253-62. PubMed ID: 18368606 [Abstract] [Full Text] [Related]
12. The meth menace: battling the fast-paced spread of methamphetamine may mean attacking it from several fronts. Boulard G. State Legis; 2005 May; 31(5):14-8. PubMed ID: 15892208 [No Abstract] [Full Text] [Related]
13. Methamphetamine: geographic areas and populations at risk, and emerging evidence for effective interventions. Degenhardt L, Baker A, Maher L. Drug Alcohol Rev; 2008 May; 27(3):217-9. PubMed ID: 18368601 [No Abstract] [Full Text] [Related]
14. Evidence of methamphetamine exposure in children removed from clandestine methamphetamine laboratories. Grant P, Bell K, Stewart D, Paulson J, Rogers K. Pediatr Emerg Care; 2010 Jan; 26(1):10-4. PubMed ID: 20042914 [Abstract] [Full Text] [Related]
15. The rise of methamphetamine in Southeast and East Asia. McKetin R, Kozel N, Douglas J, Ali R, Vicknasingam B, Lund J, Li JH. Drug Alcohol Rev; 2008 May; 27(3):220-8. PubMed ID: 18368602 [Abstract] [Full Text] [Related]
19. A review of the clinical pharmacology of methamphetamine. Cruickshank CC, Dyer KR. Addiction; 2009 Jul; 104(7):1085-99. PubMed ID: 19426289 [Abstract] [Full Text] [Related]
20. DARK Classics in Chemical Neuroscience: Methamphetamine. Abbruscato TJ, Trippier PC. ACS Chem Neurosci; 2018 Oct 17; 9(10):2373-2378. PubMed ID: 29602278 [Abstract] [Full Text] [Related] Page: [Next] [New Search]